Applied Genetic Technologies Corp. buy melinda
Start price
22.09.17
/
50%
€3.60
Target price
02.10.17
€5.00
Performance (%)
14.58%
End price
02.10.17
€4.13
Summary
This prediction ended on 02.10.17 with a price of €4.13. The prediction had a final performance of 14.58%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Applied Genetic Technologies Corp. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread Applied Genetic Te. diskutieren
Applied Genetic Technologies Corp. ist ein Biotechnologie - Unternehmen in der klinischen Phase, das in der Entwicklung der Gentherapie Produkte entwickelt , zu transformieren , das Leben von Patienten mit schweren Erkrankungen in der Ophthalmologie eingreift. Die Produkte sind so konzipiert , Retinoschisis mit X verknüpft behandeln
Stopped prediction by melinda for Applied Genetic Technologies Corp.
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€4.00
08.04.19
08.04.19
€5.86
04.11.21
04.11.21
-14.11%
01.07.21
01.07.21
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€2.89
12.01.19
12.01.19
€4.06
22.01.19
22.01.19
-12.81%
22.01.19
22.01.19
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€3.25
22.09.17
22.09.17
€4.51
02.10.17
02.10.17
14.58%
02.10.17
02.10.17